News
Portal Chicago portfolio company, Grove Biopharma, announces $30M Series A!
Our Chicago-based portfolio company, Grove Biopharma, announced today a monster $30M Series A round to develop therapeutics against previously undruggable targets in oncology, neurodegenerative, and other diseases.
Get in touch
Chicago | Boston | Atlanta | Houston
©2025 Portal Innovations, LLC
Sign up for our monthly newsletter
Stay up-to-date on the latest VC, biotech, and med tech news in Chicago and across the U.S. Sign up with your email address below to get our monthly newsletter delivered to your inbox!